Friday - September 19, 2025

Lung Adenocarcinoma Competitive Landscape Intensifies With BerGenBio, Innovent, Pfizer, Roche, and Novartis Driving Innovation | DelveInsight

Lung Adenocarcinoma – Market Insight, Epidemiology And Market Forecast – 2032 The Lung Adenocarcinoma market is projected to experience robust growth through 2032, driven by an increasing incidence of the disease, advancements in targeted therapies, greater awareness and screening efforts, … Continue reading

Nonalcoholic Steatohepatitis Market is Projected for Substantial Expansion Driven by FDA Approvals, Robust Pipeline and Strategic Collaborations | DelveInsight

Nonalcoholic Steatohepatitis Market Insight, Epidemiology And Market Forecast – 2034 The nonalcoholic steatohepatitis market is poised for significant expansion with the approval of REZDIFFRA and a robust clinical development pipeline. Key companies shaping the future of NASH treatment include Inventiva … Continue reading

Freelancers HUB Launches Facebook Advertising Service to Help Canadian Businesses Drive Conversions and Growth

Freelancers HUB Facebook Advertising Service Freelancers HUB delivers tailored Facebook Advertising Service in Canada to help businesses boost visibility, generate leads, and achieve sustainable growth. LONDON, ONTARIO, CANADA – Freelancers HUB, a trusted Canadian digital marketing company, is thrilled to … Continue reading

Primary Biliary Cholangitis Market Expected to Gain Momentum Through 2034, According to DelveInsight | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai Tianqing

The Key Primary Biliary Cholangitis Companies in the market include – CymaBay Therapeutics, Inc., Zydus Therapeutics Inc., Gannex Pharma Co., Ltd., Nanjing Chia-tai Tianqing Pharma, Novartis, Merck Sharp & Dohme LLC, Mirum Pharmaceuticals, Inc., Genfit, CymaBay Therapeutics, Inc., Calliditas Therapeutics, … Continue reading

Birch Allergy Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | ALK-Abelló A/S, Allergy Therapeutics Plc., Regeneron Pharmaceuticals, Desentum, HAL Allergy Group

The Key Birch Allergy Companies in the market include – ALK-Abelló A/S, Allergy Therapeutics Plc., Regeneron Pharmaceuticals Inc., Desentum., HAL Allergy Group., Roxall Medizin GmbH., Worg Pharmaceuticals AG., S-TARget therapeutics GmbH., Adamis Pharmaceuticals Crp., and others .   DelveInsight’s “Birch … Continue reading

Melanoma Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Immatics Biotech, Replimune and BMS, IDEAYA Biosciences and Novartis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Melanoma pipeline constitutes 150+ key companies continuously working towards developing 170+ Melanoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading